Biotechnology patents: new move confuses US patents world
- PMID: 11653442
- DOI: 10.1038/302199a0
Biotechnology patents: new move confuses US patents world
Abstract
KIE: Patent attorneys are perplexed and dismayed over a surprise decision by the U.S. Patent Office to drop its earlier objections to the second Cohen-Boyer patent application, covering basic processes in recombinant DNA technology. The patent proceedings, which were closed to public access at the request of Stanford University, have resulted in confusion over the meaning of the patent law's disclosure requirement as it applies to new organisms. Meanwhile, evidence of a prior Ph.D. thesis has called into question the originality of the Cohen-Boyer process.
Similar articles
-
Cohen-Boyer patent finally issued.Science. 1984 Sep 14;225(4667):1134. doi: 10.1126/science.225.4667.1134-b. Science. 1984. PMID: 11653582
-
Further snag with Stanford patent: filing error claimed in Cohen-Boyer.Nature. 1982 Nov 11;300(5888):95-6. doi: 10.1038/300095a0. Nature. 1982. PMID: 11643815
-
Cohen-Boyer patent: licensees ponder weaknesses.Nature. 1984 Dec 6;312(5994):487. doi: 10.1038/312487a0. Nature. 1984. PMID: 11653583
-
INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.Drugs R D. 2007;8(3):176-87. doi: 10.2165/00126839-200708030-00005. Drugs R D. 2007. PMID: 17472413 Review.
-
Current Trends in Robotics in Nursing Patents-A Glimpse Into Emerging Innovations.Comput Inform Nurs. 2019 Jun;37(6):290-297. doi: 10.1097/CIN.0000000000000538. Comput Inform Nurs. 2019. PMID: 31135470 Review.
Publication types
MeSH terms
Substances
Personal name as subject
- Actions
- Actions
LinkOut - more resources
Full Text Sources